A new study aimed to determine if continuous infusion of a β-lactam antibiotic (piperacillin-tazobactam or meropenem) reduces all-cause mortality at 90 days compared to intermittent infusion
READ MORE
Patients with sepsis could be treated based on their immune system’s response to infection rather than their symptoms. New research has revealed that people’s genetic makeup signi
READ MORE
Sepsis is a life-threatening complication causing nearly 1.7 million hospitalisations and 350,000 deaths annually in the U.S. Rapid and accurate diagnosis is critical, as the risk of mortali
READ MORE
A new study published in Microbiology Spectrum reveals that the nasal microbiota of ICU patients can effectively distinguish between sepsis and non-sepsis cases, outperforming gut microbiota
READ MORE
Sepsis is a severe condition characterised by organ dysfunction due to impaired oxygen delivery and utilisation by cells. In ICUs, oxygen is often administered to sepsis patients, especially
READ MORE
Sepsis is a major cause of death and disability and a key focus of quality measures for hospitals. In-hospital mortality of sepsis patients is often used for benchmarking by researchers and
READ MORE
Sepsis causes 11 million deaths annually and is linked to post-intensive care syndrome (PICS), which includes physical impairment, reduced quality of life, and posttraumatic stress syndrome.
READ MORE
Acetaminophen (paracetamol) has several pharmacological effects that are potentially beneficial in sepsis, including analgesia, antipyresis, and cyclooxygenase-2 inhibition. Observa
READ MORE
Sepsis affects approximately 49 million people worldwide each year. To reduce the mortality rate and the global burden of sepsis, the World Health Organization has classi
READ MORE
Critical illness-related corticosteroid insufficiency (CIRCI) is commonly seen in criticall ill patients and involves systemic inflammation, hypothalamus–pituitary–adrenal axis dysregulation
READ MORE
